The 20 Best Cone-Rod Dystrophy Doctors in New York, US

. Dr. Khedr is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, and Retinal Artery Occlusion.

George Tung is an Ophthalmologist in Bellmore, New York. Dr. Tung is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Subconjunctival Hemorrhage, Dry Eye Syndrome, Eyelid Bump, and Chalazion.

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Doyne Honeycomb Retinal Dystrophy, and Cone Dystrophy.

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Howard Charles is an Ophthalmologist in Mount Kisco, New York. Dr. Charles is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Diabetic Retinopathy.

Richard Storm is a Pediatrics specialist and an Ophthalmologist in Long Beach, New York. Dr. Storm is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Adult-Onset Vitelliform Macular Dystrophy (AVMD), Doyne Honeycomb Retinal Dystrophy, Cone Rod Dystrophy Amelogenesis Imperfecta, and Stargardt Macular Degeneration.

Dr. Fisher is a clinical ophthalmologist specializing in vitreoretinal diseases. Dr. Fisher’s career is noteworthy in the areas of patient care, teaching, and research. He is the author of several textbooks in the field of vitreoretinal diseases and ultrasonography.AuthorDr. Fisher has published more than 50 scientific articles and numerous scientific exhibits and posters. He was a course director for the American Academy of Ophthalmology for over 22 years and a review editor for many prestigious ophthalmic journals. He has received numerous awards for national and international professorships and lectureships. He has also been awarded the coveted Senior Award from the American Academy of Ophthalmology.LecturesDr. Fisher has lectured throughout the United States and abroad in the areas of ultrasonography and vitreoretinal surgery, developing new techniques and instruments in his field as well as pioneering developments in ocular endoscopy. He was selected by departmental chairmen and section chiefs at major ophthalmology centers nationwide as one of the 400 best retina doctors in America.Developed InstrumentsDr. Fisher has developed numerous intraocular surgical instruments which have advanced the field of vitreoretinal surgery. These instruments include electromagnets as well as endoscopic techniques for situations where microscopic visualization is limited or impossible. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Adult-Onset Vitelliform Macular Dystrophy (AVMD), Age-Related Macular Degeneration (ARMD), Retinal Detachment, and Vitrectomy.

"Stephen H. Tsang, M.D, Ph.D. is an acclaimed clinical geneticist in the care of individuals with retinal degenerations. He has been culturing stem cells since 1992 and created the first mouse model for a recessive form of retinitis pigmentosa (RP) by applying genome engineering to stem cell technology in 1995. He successfully treated preclinical models of Pde6a, Pde6b, Mfrp, Rho, Cngb1 and autosomal recessive bestrophin retinopathies.He has expertise in designing and testing genome engineering strategies in pre-clinical models, developing patient-specific knock-in models, generating of patient cell lines and providing care to patients with a precision medicine approach. He is also leading efforts in FDA trials for gene therapies, including PDE6A, RAB geranylgeranyl transferase, RPGR, CNGB3, CNGA3 and ABCA4 retinopathies. He wrote 3 books: “Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics"" and “Stem Cell Biology and Regenerative Medicine in Ophthalmology”, Springer Press, NY; and “CRISPR Genome Surgery in Stem Cells and Disease Tissues”, Elsevier Inc. He is an elected member of several honorary societies including the American Society for Clinical Investigation, Alcon Research Institute and American Ophthalmological Society. He is consistently named to various NIH study sections (DPVS standing member 2014-8 and PED2 2022-6) and other review committees; Alcon Research Institute Grant Review Committee (2022-27), Scientific Advisory Panel - Research to Prevent Blindness (RPB, 2019-29), Chair of American Ophthalmological Society Thesis Review Committee (2022-2023). Many of his publications are in widely-read general interest journals such as Science, NEJM, Lancet, Cell Stem Cell, Nature Genetics, and Journal of Clinical Investigation, which attests to the broad impact that his work has had.Dr. Tsang received a resident teaching award in 2008 and was the Columbia Ophthalmology Basic Science Course Director (2006-2018). Dr. Tsang graduated from Johns Hopkins University, where he began his medical genetics training under the tutelage of Professor Victor A. McKusick. He received his M.D. and Ph.D. degrees from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) at Columbia University. Dr. Tsang then completed his residency at Jules Stein Eye Institute/UCLA, followed by studies with Professors Alan C. Bird and Graham E. Holder on improving the care of individuals with macular degenerations.". Dr. Tsang is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Sorsby Fundus Dystrophy, Leber Congenital Amaurosis, and Usher Syndrome.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

Ravi Radhakrishnan is an Ophthalmologist in Mount Vernon, New York. Dr. Radhakrishnan is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Adult-Onset Vitelliform Macular Dystrophy (AVMD), Usher Syndrome, Doyne Honeycomb Retinal Dystrophy, and Usher Syndrome Type 2A.

Eric Shakin is an Ophthalmologist in Westbury, New York. Dr. Shakin is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Vitrectomy.

Juan Romero is an Ophthalmologist in New City, New York. Dr. Romero is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Retinal Detachment, and Vitrectomy.

Dr. Zagelbaum is a Diplomate of the American Board of Ophthalmology (board certified) and a Fellow of the American College of Ophthalmology (F.A.A.O.) and the American College of Surgeons (F.A.C.S.). He has written textbooks in ophthalmology, as well as book chapters and peer reviewed articles. He is currently co-editing the 3rd edition of the textbook Ophthalmic Surgical Procedures.His main interests include eye trauma and sports. He is the ophthalmology consultant to The National Football League (NFL) and The Boxing/Mixed Martial Arts Commission. He has been the team ophthalmologist for the New York Jets, New York Mets, New York Islanders, and has worked with Major League Baseball (MLB) and the National Basketball Association (NBA). Dr. Zagelbaum is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Optic Atrophy Type 1, Optic Nerve Atrophy, Glaucoma, and Eyelid Bump.

David Rabady is an Ophthalmologist in Troy, New York. Dr. Rabady has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Adult-Onset Vitelliform Macular Dystrophy (AVMD), Cone-Rod Dystrophy, Cone Dystrophy, and Stargardt Macular Degeneration. Dr. Rabady is currently accepting new patients.

Andrew Krouner is an Ophthalmologist in Albany, New York. Dr. Krouner has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Stargardt Macular Degeneration, Cone-Rod Dystrophy, Usher Syndrome Type 2A, and Usher Syndrome. Dr. Krouner is currently accepting new patients.

Glenn Stoller is an Ophthalmologist in Rockville Centre, New York. Dr. Stoller is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, and Retinal Artery Occlusion.

Robert Sax is an Ophthalmologist in Albany, New York. Dr. Sax is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Adult-Onset Vitelliform Macular Dystrophy (AVMD), Cone Rod Dystrophy Amelogenesis Imperfecta, Cone-Rod Dystrophy, and Usher Syndrome. Dr. Sax is currently accepting new patients.

Robert Feldman is an Ophthalmologist in Albany, New York. Dr. Feldman is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Adult-Onset Vitelliform Macular Dystrophy (AVMD), Age-Related Macular Degeneration (ARMD), and Usher Syndrome.

Larry Berstein is an Ophthalmologist in Plainview, New York. Dr. Berstein is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Adult-Onset Vitelliform Macular Dystrophy (AVMD), Usher Syndrome, Cone Rod Dystrophy Amelogenesis Imperfecta, and Cone Dystrophy.

Manijeh Contractor is an Ophthalmologist in Albany, New York. Dr. Contractor is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. Her top areas of expertise are Adult-Onset Vitelliform Macular Dystrophy (AVMD), Stargardt Macular Degeneration, Doyne Honeycomb Retinal Dystrophy, and Cone Rod Dystrophy Amelogenesis Imperfecta. Dr. Contractor is currently accepting new patients.